Roger Adsett
Geschäftsführer bei INSMED INCORPORATED
Vermögen: 8 Mio $ am 31.05.2024
Profil
Roger Adsett's current job is Chief Operating Officer at Insmed, Inc. He previously worked as Director-Marketing & Brand at AstraZeneca PLC from 1994 to 2005.
He also held the position of Marketing Director at AstraZeneca R & D Lund and Nexium, Inc. In addition, he served as Independent Director at Landos Biopharma, Inc. from 2022 to 2024.
Prior to his current role, he was the SVP, Head-Gastrointestinal & Internal Medicine at Shire Plc from 2015 to 2016.
Mr. Adsett completed his undergraduate degree at Bucknell University and holds an MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INSMED INCORPORATED
0,09% | 17.05.2024 | 149 275 ( 0,09% ) | 8 Mio $ | 31.05.2024 |
Aktive Positionen von Roger Adsett
| Unternehmen | Position | Beginn |
|---|---|---|
| INSMED INCORPORATED | Geschäftsführer | 14.11.2019 |
Ehemalige bekannte Positionen von Roger Adsett
| Unternehmen | Position | Ende |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 23.05.2024 |
| SHIRE | Corporate Officer/Principal | 01.09.2016 |
| ASTRAZENECA PLC | Vertrieb & Marketing | 01.10.2005 |
| Nexium, Inc. | Vertrieb & Marketing | - |
| AstraZeneca R & D Lund | Vertrieb & Marketing | - |
Ausbildung von Roger Adsett
| Bucknell University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| INSMED INCORPORATED | Health Technology |
| LANDOS BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Nexium, Inc. | Finance |
| AstraZeneca R & D Lund |
